TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.70$ +50.4% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ZYBT
Line item Q4 22 Q2 23 Q4 23 Q2 24 Q4 24 Q2 25 Q3 25 Q4 25 Q1 26
– -1.1% -2.7% -2.5% +1.2% +0.0% -11.5% +0.0% +0.0%
– +1.2% -5.2% -7.7% -6.4% +0.0% -22.6% +0.0% +0.0%
– +141.5% -36.0% -52.3% +158.7% +0.0% +170.5% +0.0% +0.0%
– +141.5% -30.8% -47.7% – – +159.0% – –
– -7.6% -19.8% -7.8% -35.0% +48.6% -79.1% +0.0% +0.0%
– -2.6% +8.0% +11.8% -10.7% +0.0% -32.7% +0.0% +0.0%
– -8.5% -8.5% +51.0% -7.5% +0.0% +140.4% +0.0% +0.0%
– +15.5% -14.6% -14.2% +2.1% +0.0% -7.8% +0.0% +0.0%
– +16.5% -15.3% -8.5% -1.1% +0.0% -11.4% +0.0% +0.0%
– +45.5% +0.0% +9.4% – – -19.3% – –
– -38.2% -6.7% -8.8% +3.2% +0.0% +2.4% +0.0% +0.0%
– – +0.0% – – -2.1% – – –
– -11.8% +4.3% +3.2% +0.8% +0.0% -12.0% +0.0% +0.0%
– -53.1% +24.4% +22.9% +2.0% +0.0% -77.1% -296.4% –
– – – +0.0% +0.0% +0.5% +0.0% +0.0% +0.0%

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?